Prasad Raju bought CRSP
March 20, 2024 · Form 4 insider transaction
Prasad Raju bought 36,168 shares of CRISPR Therapeutics AG at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
36,168
Price
$0.00
Total value
N/A
InsiderPrasad Raju
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 20, 2024
Filing dateMarch 22, 2024
Shares owned after36,168
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option was granted on March 20, 2024 with respect to 36,168 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 20, 2024.